Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
06:55pm, Thursday, 20'th Jun 2024
In the most recent trading session, Adma Biologics (ADMA) closed at $10.71, indicating a +0.85% shift from the previous trading day.
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
10:30am, Tuesday, 11'th Jun 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
02:34pm, Friday, 07'th Jun 2024
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
02:34pm, Friday, 07'th Jun 2024
The top five biotech stocks today have several commonalities. Among them are strong ratings.
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Titanium Metal Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The global t
5 Stocks With Recent Price Strength to Tap May's Rally
09:06am, Wednesday, 15'th May 2024
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ADMA, NTIC, AGS, MBIN, STRA.
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
10:46am, Monday, 13'th May 2024
Here is how Adma Biologics (ADMA) and ResMed (RMD) have performed compared to their sector so far this year.
ADMA Biologics, Inc. (ADMA) Q1 2024 Earnings Call Transcript
11:11pm, Thursday, 09'th May 2024
ADMA Biologics, Inc. (NASDAQ:ADMA ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 AM ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Grossm
Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates
07:21pm, Thursday, 09'th May 2024
Adma Biologics (ADMA) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to loss of $0.03 per share a year ago.
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
04:05pm, Thursday, 09'th May 2024
1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y 1Q 2024 Adjusted EBITDA ( 1 ) of $26.4 Million, a 970% Increase Y-
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
06:51pm, Thursday, 02'nd May 2024
Adma Biologics (ADMA) reachead $6.74 at the closing of the latest trading day, reflecting a +1.05% change compared to its last close.
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
07:00am, Thursday, 02'nd May 2024
RAMSEY, N.J. and BOCA RATON, Fla.
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
10:35am, Tuesday, 30'th Apr 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
What's in Store for ADMA Biologics (ADMA) in Q1 Earnings?
12:31pm, Monday, 29'th Apr 2024
On ADMA Biologics' (ADMA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed products, Bivigam, Asceniv and Nabi-HB.
3 'Buy-Rated' Biotech Stocks Under $10
04:39am, Sunday, 28'th Apr 2024
Today, we look at three small-cap biotech/biopharma stocks. All three have attractive risk/reward profiles and potential catalysts on the horizon. An investment synopsis on all three firms is presente
